A key congressional committee met on Tuesday to consider more than 1,200 amendments to a large-scale defense bill, including about a dozen measure related to marijuana and psychedelics. Several of those major proposed drug policy reforms have now been cleared for votes on the House floor this week.
The House Rules Committee took up the National Defense Authorization Act (NDAA), determining which amendments could be made in order for floor consideration. Most—such as measures covering cannabis banking, medical marijuana recommendations for military veterans and the therapeutic benefits of psilocybin for military personnel—made the panel’s cut and are now set to be considered by the full chamber.
Lawmakers have tried to attach drug policy reform to NDAA in past sessions, with mixed results. For the current Fiscal Year 2023 bill, however, there seemed to be even wider, bipartisan interest in using the defense bill as a vehicle for cannabis and psychedelics policy.
Two marijuana measures were already added to NDAA in the House Armed Services Committee, including one from Rep. Anthony Brown (D-MD) that concerns cannabis sentencing standards under military code, mandating that the Military Justice Review Panel “develop recommendations specifying appropriate sentencing ranges for offenses involving the use and possession
Read full article on Marijuana Moment
